Duration of antibody responses following severe acute respiratory syndrome coronavirus 2 infection.

Duration of antibody responses following severe acute respiratory syndrome coronavirus 2 infection.
复制标题

严重急性呼吸综合征冠状病毒 2 感染后抗体反应的持续时间

DOI:
10.1007/s11845-021-02860-4
复制
发表时间:
2022-12
影响因子:
2.1
通讯作者:
Li G
Li G
中科院分区:
医学4区
文献类型:
--
作者:
Jiang Y;Wei X;Wang H;Li G

文献摘要

参考文献

相似文献

关于SARS冠状病毒2型(SARS-CoV-2)感染后患者体内抗SARS-CoV-2免疫球蛋白G(IgG)抗体的持续时间知之甚少。我们的目的是确定SARS-CoV-2感染后免疫球蛋白G(IgG)和M(IgM)抗体应答的持续时间,并评估短期抗SARS-CoV-2 IgG的危险因素。我们测量了94名从SARS-CoV-2感染中恢复的患者的抗体应答。采用卡方检验和多因素Logistic回归分析确定短期(< 6个月)抗SARS-CoV-2 IgG的危险因素。IgG抗体检测在所有患者,直到4个月,19(21.8%)恢复期患者恢复到IgG阴性4-6个月后症状发作。IgM抗体在症状发作后4-6个月显著下降至5.7%。患者特征与可检测IgG的持续时间短无关。相当一部分康复者在SARS-CoV-2感染后可能表现出短暂的IgG应答。我们的研究结果表明,从SARS-CoV-2感染中恢复的患者,如果他们的抗SARS-CoV-2 IgG抗体检测不到,也应该接种疫苗。
Little is known on the duration of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibodies in patients following SARS-CoV-2 infection. We aimed to determine the duration of the immunoglobulin G (IgG) and M (IgM) antibody responses following SARS-CoV-2 infection and to evaluate the risk factors for a short duration of anti-SARS-CoV-2 IgG. We measured antibody responses in 94 patients who had recovered from SARS-CoV-2 infection. The chi-square test and multivariable logistic regression analysis were used to identify risk factors for a short duration (< 6 months) of anti-SARS-CoV-2 IgG. IgG antibodies were detectable in all patients until 4 months; 19 (21.8%) convalescent patients reverted to IgG negative 4–6 months after symptom onset. IgM antibodies decreased significantly to 5.7% at 4–6 months after symptom onset. Patient characteristics were not associated with a short duration of detectable IgG. A substantial fraction of convalescents may exhibit a transient IgG response following SARS-CoV-2 infection. Our findings suggest that patients who have recovered from SARS-CoV-2 infection should also be vaccinated if their anti-SARS-CoV-2 IgG antibodies are undetectable.
DOI: 10.1016/s0140-6736(20)30183-5
发表时间: 2020-02-15
期刊: LANCET
影响因子: 168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者: Cao, Bin
DOI: 10.1016/j.immuni.2020.04.023
发表时间: 2020-06-16
期刊: IMMUNITY
影响因子: 32.4
作者:
Ni, Ling;Ye, Fang;Dong, Chen
通讯作者: Dong, Chen
DOI: 10.1056/nejmoa2026116
发表时间: 2020-10-29
影响因子: 158.5
作者:
Gudbjartsson, Daniel F.;Norddahl, Gudmundur L.;Stefansson, Kari
通讯作者: Stefansson, Kari
DOI: 10.1038/s41591-020-0965-6
发表时间: 2020-06-18
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Long, Quan-Xin;Tang, Xiao-Jun;Huang, Ai-Long
通讯作者: Huang, Ai-Long
DOI: 10.1183/13993003.00763-2020
发表时间: 2020-08-01
影响因子: 24.3
作者:
Lou, Bin;Li, Ting-Dong;Chen, Yu
通讯作者: Chen, Yu